FindTrial
Sign In

Comparative outcomes of low and high dose corticosteroid in subacromial injection for impingement syndrome

Comparative outcomes of low and high dose corticosteroid in subacromial injection for impingement syndrome: randomised double-blind study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20181214002
Enrollment
30
Registered
2018-12-14
Start date
2019-03-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patient with shoulder pain Subacromial impingement syndrome subacromial steroid injection shoulder pain

Interventions

subacromion triamcinolone acetonide injection,subacromion triamcinolone acetonide injection
Active Comparator Drug,Experimental Drug
40 mg Triamcinolone group,10 mg Triamcinolone group

Sponsors

Orthopedics department, Hatyai hospital
Lead Sponsor
Orthopedics department&#44
Collaborator
Hatyai hospital
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Shoulder pain from Subacromial Impingement Syndrome can complete questionnaire

Exclusion criteria

Exclusion criteria: Shoulder pain from other pathophysiology history of trauma around shoulder 3 months before history of steroid allergy infection or wound at inject area psychosis or schizophrenia

Design outcomes

Primary

MeasureTime frame
efficacy of corticosteroid 12 months after end of the intervention ASES shoulder score—

Secondary

MeasureTime frame
Satisfaction, complication of steroid injection 12 months after end of the intervention questionnaires—

Countries

Thailand

Contacts

Public ContactPongtep Na Nakorn

Hatyai hospital

dr.pongtep@hotmail.com0815408973

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026